Drug Trial Radar · NCT02132247
Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries
Last checked: Nov 20, 2026Latest source record: May 11, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
104
Actual
Start
May 2014
Primary completion
Oct 2016
Study completion May 2017
Sponsor
- Lead sponsor
- IBSA Institut Biochimique SAIndustry
- Sponsor type
- Industry
- First posted
- May 7, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 years, up to 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to determine whether Flector Patch is safe for use in children. The secondary purpose is to assess blood levels of diclofenac, the active ingredient in Flector Patch.
Conditions
- Athletic Injuries
Interventions
Diclofenac hydroxyethylpyrrolidineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dermatologic Assessment at the Patch Application SiteTime frame: Up to 2 weeks, depending upon pain resolution
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Applied Research Center of Arkansas
Little Rock, Arkansas
SCORE Physician Alliance
St. Petersburg, Florida
Pediatrics and Adolescent Medicine P.A.
Marietta, Georgia
Arlington Family Research Center Inc.
Arlington, Texas
Utah Valley Pediatrics
Orem, Utah
J. Lewis Research Inc./Foothill Family Clininc
Salt Lake City, Utah
J. Lewis Research Inc./FirstMed East
Salt Lake City, Utah
J. Lewis Research Inc./Foothill Family Clinic South
Salt Lake City, Utah
Legacy Point Family Medicine
West Point, Utah
Pediatric Research of Charlottesville
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.